Lecznica Weterynaryjna Zwierzyniec II S.C.

Lecznica Weterynaryjna Zwierzyniec II S. C. operates in Poland, providing essential veterinary services for companion animals, including diagnostics, surgeries, and wellness care to ensure pet health and safety. Founded in 2007 and headquartered in Gdynia, Poland, Lecznica Weterynaryjna Zwierzyniec II S.

C. focuses on veterinary care for pets. The company has undergone no significant pivots in business strategy and does not have any known subsidiaries. They completed their first funding deal in August 2025, when IVC Evidensia acquired Lecznica Weterynaryjna Zwierzyniec II S.

C. Lecznica Weterynaryjna Zwierzyniec II S. C. specializes in comprehensive veterinary care for companion animals, offering a wide range of diagnostic and therapeutic services.

The clinic is equipped with state-of-the-art technology for advanced procedures in internal medicine, soft and hard tissue surgery, dentistry, cardiology, dermatology, and ophthalmology. Services include vaccinations, health monitoring for post-surgical patients, and issuing pet passports and microchip implants, addressing both routine and emergency medical needs for pet owners in the Trójmiasto area, specifically Gdynia and Gdańsk. The revenue model for Lecznica Weterynaryjna Zwierzyniec II S. C.

is based on direct transactions with pet owners paying for veterinary services. Services are billed on a per-service basis, including consultations, diagnostics, surgeries, and follow-up care. The clinic follows a fee-for-service model, which means clients are charged according to specific services provided, such as soft tissue surgeries or diagnostic imaging like X-rays and ultrasound. Additional income is generated from routine wellness packages that include vaccinations and health checks for established pet owners within the community.

Lecznica Weterynaryjna Zwierzyniec II S. C. has strategic plans for future growth, focusing on expanding its service offerings and potentially entering new markets. The details regarding new products or services are not specified, but the company aims to enhance its veterinary services further.

Following the acquisition by IVC Evidensia in August 2025, the clinic is expected to leverage additional resources for growth initiatives and operational improvements.